Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Clinipace To Manage Two Phase II Clinical Trials For Inspire Pharmaceuticals
Clinipace, a digital clinical research organization, announced that Inspire Pharmaceuticals, Inc. has selected the company to manage and deploy two phase II studies for the ophthalmic prescription medicine, AzaSite®.
generic viagra online
For America's Aged, Surgery At Any Price?
When doctors decide whether or not to go ahead with an expensive surgery, "age is no longer the deciding factor, even for invasive treatment such as open-heart surgery," The Philadelphia Inquirer reports. One question is "whether this never-too-old approach is an example of U.S. medical progress, or an example of why Medicare -- federal health insurance for people over 64 -- is headed for insolvency. The answer, experts say, is both. Which is why the current debate over expanding federal coverage to all uninsured Americans is an ethical and economic minefield. "Forty years ago, it was taken for granted that the elderly were not good candidates for organ transplantation, dialysis, or advanced surgical procedures. That has changed," Daniel Callahan, cofounder of the Hastings Center, a bioethics research institute in Garrison, N.Y., wrote recently. "Under the best of circumstances, age should be irrelevant in the Medicare program. But so far, the cost of care has not been considered, and it can hardly remain irrelevant in a program strapped for money.""
plastic surgery before after
News of the day
Bayer Schering Pharma Presents Positive Results Of Phase II Study With Riociguat
Positive data from a
Nutrition

Infant Medicine Feeder Delivers Incorrect Dose

Parents of babies and young children are being urged to stop using the "First Steps" medicine feeder range manufactured by RSW International Ltd after the Medicines and Healthcare products Regulatory Agency (MHRA) uncovered potential safety and quality concerns. The MHRA was recently alerted to the product being distributed nationwide and sold for one pound in discount retail outlets, and on eBay, after a six month old baby was admitted to hospital in the North West from an overdose while using the device. RSW International have recalled all remaining stock, however, parents may still have this product in their home. MHRA Director of Device Technology and Safety, Clive Bray, said he "strongly advised" people to stop using these medicine feeders which are marketed for the administration of liquid medicines to babies and young children. "There is no evidence that the safety, quality or performance of this product has been assessed to the current standard," he said. "The product could pose a potential risk to babies or young children as the measuring scale is confusing and could be inaccurate. "This may have caused the reported overdose and we are strongly advising parents to stop using, and dispose of this product." Notes 1. The MHRA is the government agency responsible for ensuring that medicines and medical devices work, and are acceptably safe. No product is risk-free. Underpinning all our work lie robust and fact-based judgments to ensure that the benefits to patients and the public justify the risks. We keep watch over medicines and devices, and take any necessary action to protect the public promptly if there is a problem. We encourage everyone - the public and healthcare professionals as well as the industry - to tell us about any problems with a medicine or medical device, so that we can investigate and take any necessary action. http://www.mhra.gov.uk MHRA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009